ACLASTA can have side effects. If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist. Side effects related to the first infusion are very common (occurring in more than 40% of patients) but are less common following subsequent infusions. The majority of the side effects, such as fever and chills, pain in the muscles or joints, and headache, occur within the first three days following the dose of ACLASTA. The symptoms are usually mild to moderate and go away within three days of starting. Your doctor can recommend a mild pain reliever such as ibuprofen or paracetamol to make you feel more comfortable. The chance of experiencing these side effects decreases with subsequent doses of ACLASTA.
Skin reactions such as redness, swelling and/or pain at the infusion site may occur. ACLASTA may cause swelling, redness, pain and itching to the eyes or eye sensitivity to light, pain in the mouth, teeth and jaw, swelling of sores inside the mouth, numbness or a feeling of heaviness in the jaw, or loosening of a tooth. These could be signs of bone damage in the jaw (osteonecrosis). Tell your dentist immediately if you experience such symptoms. Irregular heart rhythm (atrial fibrillation) has been seen in patients receiving ACLASTA for postmenopausal osteoporosis. It is currently unclear whether ACLASTA causes this irregular heart rhythm but you should report it to your doctor if you experience such symptoms after you have received ACLASTA. Kidney disorders (e.g. decreased urine output) may occur. Your doctor may do a blood test to check your kidney function before each dose of ACLASTA. It is important for you to drink at least 2 glasses of fluid (such as water), within a few hours before receiving ACLASTA, as directed by your healthcare provider.
Treatment of postmenopausal osteoporosis, osteoporosis in men and Paget’s disease of bone, Prevention of clinical fractures after hip fracture, Treatment of glucocorticoid-induced osteoporosis.
Very common side effect (affecting 10 or more in every 100 patients): Fever.
Common side effects (affecting less than 10 in every 100 patients): Headache, dizziness, sickness, vomiting, diarrhoea, muscle pain, joint pain, bone pain, back pain, pain in your hands and/or feet, flu-like symptoms (e.g. tiredness, chills, joint and muscle pain), chills, being tired and uninterested, weakness, pain, feeling unwell. In addition in patients with Paget’s disease: symptoms due to low blood calcium, such as muscle spasms, or numbness, or a tingling sensation especially in the area around the mouth, shortness of breath.
Uncommon side effects (affecting less than 1 in every 100 patients): Flu, upper respiratory tract infections, decreased red cell count, loss of appetite, sleeplessness, reduced alertness and awareness, tingling sensation or numbness, drowsiness, trembling, temporary loss of consciousness, swelling or infection of the membrane lining the eyelids, eye infection, irritation and inflammation with pain and redness, spinning sensation, increased blood pressure, flushing, cough, shortness of breath, upset stomach, abdominal pain, constipation, dry mouth, heartburn, skin rash, excessive sweating, itching, skin reddening, neck pain, stiffness in muscles, bones and/or joints, joint swelling, muscle spasms, shoulder pain, pain in your chest muscles and rib cage, joint inflammation, muscular weakness, abnormal kidney test results, kidney failure, abnormal frequent urination, swelling of hands, ankles or feet, thirst, acute phase reaction (the body’s immune response to ACLASTA e.g. muscle pain and fever), non-cardiac chest pain.
Rare side effects (affecting less than 1 in every 1,000 patients): Swelling mainly of the face and throat, kidney disorder (e.g. decreased urine output).
Very rare side effects (affecting less than 1 in every 10,000 patients): Severe allergic reaction including dizziness and difficulty breathing, dehydration secondary to post-dose symptoms such as fever, vomiting and diarrhoea; decreased blood pressure; pain in the mouth, teeth and jaw, swelling of sores inside the mouth, numbness or a feeling of heaviness in the jaw, or loosening of a tooth.
Additional observed side effects: Disturbed sense of taste, toothache, stomach pain, sensation of forceful and/or irregular heart beat, skin reaction at the infusion site, eye sensitivity to light.
Reporting of side effects: If you get side effects, talk to your doctor or pharmacist. You can also report side effects to SAHPRA via the “6.04 Adverse Drug Reaction Reporting Form”, found online under SAHPRA’s publications: https://sahpra.org.za/wp-content/uploads/2020/01/%206.04_ARF1_v5.1_27Jan2020.pdf. By reporting side effects, you can help provide more information on the safety of ACLASTA. Suspected adverse reactions can also be reported directly to the HCR via [email protected].